Ayu Latifah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayu Latifah has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Achmad Zaki
Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, Tangerang Selatan 15419, Indonesia
2 shared publications - Chris Adhiyanto
Syarif Hidayatullah State Islamic Univ, Fac Med, Med Res Lab, Jakarta, Indonesia
2 shared publications - Gema Puspa Sari
Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, Tangerang Selatan 15419, Indonesia
2 shared publications - Laifa Annisa Hendarmin
Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, Tangerang Selatan 15419, Indonesia
2 shared publications - Mella Ferania
Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, Tangerang Selatan 15419, Indonesia
2 shared publications - Sakorn Pornprasert
Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
2 shared publications
Latest Publications
- Open Access
- 14 July 2026
- Published by MDPI AG in Thalassemia Reports
- Vol. 16 (3) , 15
Molecular Identification and Familial Segregation of the Hb Malay (HBB:c.59A>G) Variant in a Three-Generation Indonesian Family
Background/Objectives: Beta-thalassemia (β-thal) is an inherited hemoglobin disorder caused by mutations in the HBB gene. Hb Malay (HBB:c.59A>G [NM_000518.5], p.Asn20Ser, CD19), a missense substitution (AAC→AGC; Asn→Ser) in exon 1 of the β-globin gene causing β+-thalassemia, has been mainly described in Southeast Asian populations but remains underreported in published Indonesian molecular epidemiology literature. This study aimed to identify the Hb Malay variant and investigate its familial segregation in a large Indonesian extended family. Methods: Cascade molecular screening was initiated following detection of the mutation in a proband referred for genetic testing. Sixteen individuals (one proband and 15 family members) consented to participate. Genomic DNA was extracted from peripheral blood and a 1.9-kb β-globin gene fragment was amplified by PCR. Mutation screening was performed using the Thalassemia GenoArray Kit HBGA-THAL-b31 (Hybribio) and confirmed by Sanger sequencing. A three-generation pedigree was constructed from molecular results and family interviews. Results: The Hb Malay mutation (HBB:c.59A>G) was identified in 13 of 16 individuals: 12 heterozygous carriers (A/G) and one homozygous individual (G/G, subject III-1, aged 15 years). Three individuals showed the normal genotype (A/A). Pedigree analysis demonstrated autosomal recessive inheritance across three generations. No α-globin deletions covered by the GenoArray panel were detected. Conclusions: To our knowledge, this is one of the few documented reports of cascade molecular screening for the Hb Malay (HBB:c.59A>G) variant in a large extended Indonesian family, confirmed by dual molecular methods. These findings illustrate the potential value of cascade molecular screening for early carrier identification in settings where hemoglobin fractionation testing is unavailable, and highlight the need for population-based epidemiological studies to guide thalassemia prevention policy in Indonesia.
- 14 July 2026
- Published by MDPI AG in Thalassemia Reports
- Vol. 16 (3) , 15
Open AccessMolecular Identification and Familial Segregation of the Hb Malay (HBB:c.59A>G) Variant in a Three-Generation Indonesian Family
Background/Objectives: Beta-thalassemia (β-thal) is an inherited hemoglobin disorder caused by mutations in the HBB gene. Hb Malay (HBB:c.59A>G [NM_000518.5], p.Asn20Ser, CD19), a missense substitution (AAC→AGC; Asn→Ser) in exon 1 of the β-globin gene causing β+-thalassemia, has been mainly described in Southeast Asian populations but remains underreported in published Indonesian molecular epidemiology literature. This study aimed to identify the Hb Malay variant and investigate its familial segregation in a large Indonesian extended family. Methods: Cascade molecular screening was initiated following detection of the mutation in a proband referred for genetic testing. Sixteen individuals (one proband and 15 family members) consented to participate. Genomic DNA was extracted from peripheral blood and a 1.9-kb β-globin gene fragment was amplified by PCR. Mutation screening was performed using the Thalassemia GenoArray Kit HBGA-THAL-b31 (Hybribio) and confirmed by Sanger sequencing. A three-generation pedigree was constructed from molecular results and family interviews. Results: The Hb Malay mutation (HBB:c.59A>G) was identified in 13 of 16 individuals: 12 heterozygous carriers (A/G) and one homozygous individual (G/G, subject III-1, aged 15 years). Three individuals showed the normal genotype (A/A). Pedigree analysis demonstrated autosomal recessive inheritance across three generations. No α-globin deletions covered by the GenoArray panel were detected. Conclusions: To our knowledge, this is one of the few documented reports of cascade molecular screening for the Hb Malay (HBB:c.59A>G) variant in a large extended Indonesian family, confirmed by dual molecular methods. These findings illustrate the potential value of cascade molecular screening for early carrier identification in settings where hemoglobin fractionation testing is unavailable, and highlight the need for population-based epidemiological studies to guide thalassemia prevention policy in Indonesia.
- Open Access
- 24 June 2026
- Published by MDPI AG in Preprints.org
Molecular Characterization of the Hb Malay (HBB:c.59A>G) Mutation and Its Familial Segregation in a Three-Generation Indonesian Family
Background/Objectives: Beta-thalassemia (β-thal) is an inherited hemoglobin disorder caused by mutations in the HBB gene. Hb Malay (HBB:c.59A>G, CD19), a missense substitution (AAC→AGC; Asn→Ser) in exon 1 of the β-globin gene causing β⁺-thalassemia, has been mainly described in Southeast Asian populations but remains rarely documented in Indonesia. This study aimed to identify the Hb Malay mutation and investigate its familial segregation in an Indonesian extended family. Methods: Cascade molecular screening was initiated following detection of the mutation in a proband referred for genetic testing. Sixteen family members consented to participate. Genomic DNA was extracted from peripheral blood and a 1.9-kb β-globin gene fragment was amplified by PCR. Mutation screening was performed using the GenoArray Thalassemia Detection Kit (Hybribio) and confirmed by Sanger sequencing. A three-generation pedigree was constructed from molecular results and family interviews.Results: The Hb Malay mutation (HBB:c.59A>G) was identified in 13 of 16 individuals: 12 heterozygous carriers (A/G) and one homozygous individual (G/G, subject KA, aged 15 years). Three individuals showed the normal genotype (A/A). Pedigree analysis demonstrated autosomal recessive inheritance across three generations. No α-globin deletions were detected. Conclusions: This is the first report of a large Indonesian family carrying the Hb Malay variant, confirmed by dual molecular methods. These findings highlight the importance of cascade molecular screening for early carrier identification, particularly where hemoglobin fractionation testing is unavailable.
- 24 June 2026
- Published by MDPI AG in Preprints.org
Open AccessMolecular Characterization of the Hb Malay (HBB:c.59A>G) Mutation and Its Familial Segregation in a Three-Generation Indonesian Family
Background/Objectives: Beta-thalassemia (β-thal) is an inherited hemoglobin disorder caused by mutations in the HBB gene. Hb Malay (HBB:c.59A>G, CD19), a missense substitution (AAC→AGC; Asn→Ser) in exon 1 of the β-globin gene causing β⁺-thalassemia, has been mainly described in Southeast Asian populations but remains rarely documented in Indonesia. This study aimed to identify the Hb Malay mutation and investigate its familial segregation in an Indonesian extended family. Methods: Cascade molecular screening was initiated following detection of the mutation in a proband referred for genetic testing. Sixteen family members consented to participate. Genomic DNA was extracted from peripheral blood and a 1.9-kb β-globin gene fragment was amplified by PCR. Mutation screening was performed using the GenoArray Thalassemia Detection Kit (Hybribio) and confirmed by Sanger sequencing. A three-generation pedigree was constructed from molecular results and family interviews.Results: The Hb Malay mutation (HBB:c.59A>G) was identified in 13 of 16 individuals: 12 heterozygous carriers (A/G) and one homozygous individual (G/G, subject KA, aged 15 years). Three individuals showed the normal genotype (A/A). Pedigree analysis demonstrated autosomal recessive inheritance across three generations. No α-globin deletions were detected. Conclusions: This is the first report of a large Indonesian family carrying the Hb Malay variant, confirmed by dual molecular methods. These findings highlight the importance of cascade molecular screening for early carrier identification, particularly where hemoglobin fractionation testing is unavailable.